Krónikus limfoid leukémia (CLL): vizsgálatok itt: Lengyelország
36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Where
- Cracow, Gdansk, Wroclaw
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2022-501876-24-00 - 1. fázisTaking peopleA Study to Test How Safe, Effective and How the Body Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Where
- Cracow, Lublin, Wroclaw
- Életkor
- 18 év and over
- People
- 22 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2024-514152-32-00 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Katowice, Krakow, Lublin, Skórzewo, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 4. fázisNot yet taking people in LengyelországPhase IV VR in relapsed CLL – Polish experience
- Where
- Bydgoszcz, Lodz, Lublin, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 36
- Run by
- Uniwersytet Medyczny W Lublinie
See details and how to join2025-524795-35-00 - 3. fázisTaking peopleGlobal Trial in APG2575 for Patients With CLL/SLL
- Where
- Bydgoszcz, Cracow, Lodz, Skorzewo, Wroclaw
- Életkor
- 18 év to 99 év
- People
- 400 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00 - 3. fázisTaking peopleA Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
- Where
- Bydgoszcz, Cracow, Gdansk, Gdynia, Katowice, Legnica, Lublin, Opole, Skorzewo, Slupsk, Walbrzych, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Dizal Pharmaceuticals
See details and how to joinNCT07139873 · EU 2025-522669-32-00 - 4. fázisTaking peopleA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Where
- Krakow, Warsaw
- Életkor
- 18 év and over
- People
- 787 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876649 - 4. fázisTaking peopleA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Where
- Krakow, Warsaw
- Életkor
- 18 év and over
- People
- 279 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876662 - 1. fázisBefejeződöttStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Gdansk, Lodz, Warsaw
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 3. fázisTaking peopleAVO-CLL: a phase III multicenter, randomized, open-label, clinical trial comparing efficacy and safety of acalabrutinib in combination with obinutuzumab versus venetoclax in combination with obinutuzumab in the first-line treatment of newly diagnosed patients with chronic lymphocytic leukemia
- Where
- Bia?ystok, Gdansk, Legnica, Łódź, Walbrzych, Warsaw, Wroc?aw
- Életkor
- 18 év and over
- People
- 72
- Run by
- Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego
See details and how to join2023-508423-13-00 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Gdansk, Gliwice, Krakow, Wroclaw
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394